Our mission is to invent, patent, develop and commercialise a new generation of innovative electrodes for implantation in the brain and spinal cord. Main focus is on the development of implantable neural interfaces that outmatch competitors. Neuronano intends to make its technology available to patients by entering into commercial collaboration with a suitable partner capable of providing and distributing high quality solutions on a worldwide scale.

Our vision is to develop groundbreaking “Neuromodulation” technologies (alternative or complementary) to pharmacological treatments for e.g. Parkinson's disease, epilepsia, depression, pain and itch control, control of movements in disabled persons, and also develop a future generation of research instruments for high definition brain research with regard to memory and learning.